Almitas Capital »

Bio-Rad Laboratories shares owned by Almitas Capital

Quarter-by-quarter ownership of Bio-Rad Laboratories (BIO) shares owned by Almitas Capital from 13F filings

Historical chart of Almitas Capital investment in Bio-Rad Laboratories

Tip: Access up to 7 years of quarterly data

All positions including Bio-Rad Laboratories held by Almitas Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bio-Rad Laboratories by Almitas Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.4M 30k 278.75

More positions owned by Almitas Capital

Fidelity Wise Origin Bitcoin SHS (FBTC)
Blackrock Mun Target Term Tr Com Shs Ben In (BTT)
Asa Gold And Precious Mtls L SHS (ASA)
Amylyx Pharmaceuticals (AMLX)
Design Therapeutics (DSGN)
Nuveen PA Investnt Quality Municipal (NQP)
Pimco Dynamic Income Strateg Com Shs Ben Int (PDX)
Lyell Immunopharma Com New (LYEL)
Bio Rad Labs Cl A (BIO)
Cannae Holdings (CNNE)
Cornerstone Total Rtrn Fd In (CRF)
Blackrock Health Sciences Te Com Shs (BMEZ)
Alx Oncology Hldgs (ALXO)
Brightspire Capital Com Cl A (BRSP)
Bny Mellon Strategic Municipal Bond Fund closed end income funds non-taxable (DSM)

View all positions for Almitas Capital

Top funds holding Bio-Rad Laboratories

First Eagle Investment Management
Vanguard Group
BlackRock
Dimensional Fund Advisors
Vanguard Capital Management
Vanguard Portfolio Management
Ariel Investments
Earnest Partners
State Street Corporation
Capital World Investors
Bank of America Corporation
Ubs Global Asset Management Americas
First Pacific Advisors
Massachusetts Financial Services
Capital Research Global Investors

View all funds holding Bio-Rad Laboratories